Restoration of the Striatal Dopamine Synthesis for Parkinson's Disease:Viral Vector-Mediated Enzyme Replacement Strategy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|7|2|109-120

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.7, Iss.2, 2007-04, pp. : 109-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Viral Vector-Mediated Gene Therapy for Hemophilia

By  

Current Gene Therapy, Vol. 1, Iss. 3, 2001-09 ,pp. : 301-315

Bentham Science Publishers

Access to resources Recommend Favorite

Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System

By Pérez-Martínez Francisco   Guerra Javier   Posadas Inmaculada   Ceña Valentín  

Pharmaceutical Research, Vol. 28, Iss. 8, 2011-08 ,pp. : 1843-1858

Springer Publishing Company

Access to resources Recommend Favorite

The Potential of Viral Vector-Mediated Gene Transfer to Prolong Corneal Allograft Survival

By  

Current Gene Therapy, Vol. 9, Iss. 1, 2009-02 ,pp. : 33-44

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine agonists in Parkinson’s disease

By Tintner Ron   Jankovic Joseph  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Dopamine Agonists in Parkinson's Disease

By Lange K.W.  

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 381-389

Adis International

Access to resources Recommend Favorite